Cardiac remodeling pathways do not accelerate disease onset and severity in a mouse model of PLN-R14del

Liu Sun1, Elisabeth M Schouten1, Karla Arevalo Gomez1

  • 1Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Scientific Reports
|October 9, 2025
PubMed

Insights

Cardiac pressure overload from transverse aortic constriction (TAC) did not accelerate disease in a Phospholamban (PLN)-R14del mouse model. Common cardiac stress pathways alone are insufficient to trigger PLN-R14del cardiomyopathy.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Disease Modeling

Background:

  • Phospholamban (PLN)-R14del is a pathogenic variant linked to ventricular arrhythmias and dilated cardiomyopathy.
  • Disease onset and severity in PLN-R14del carriers show high heterogeneity, suggesting other factors influence progression.

Purpose of the Study:

  • To investigate if cardiac pressure overload, induced by transverse aortic constriction (TAC), accelerates disease onset in a heterozygous PLN-R14del mouse model (R14Δ/+) .

Main Methods:

  • A heterozygous PLN-R14del mouse model (R14Δ/+) underwent TAC surgery to induce pressure overload.
  • Wild-type littermates and sham-operated controls were used for comparison.
  • Cardiac structure, function, gene expression, and sarco-endoplasmic reticulum integrity were assessed post-surgery.

Main Results:

  • TAC induced cardiac remodeling (increased wall thickness, ventricular/atrial weights, reduced ejection fraction) in both R14Δ/+ and wild-type mice.
  • Gene expression analysis revealed comparable activation of cardiac remodeling and stress pathways in both groups.
  • Importantly, TAC did not induce sarco-endoplasmic reticulum malformation in R14Δ/+ mice, indicating PLN-R14del-specific pathology was not triggered.

Conclusions:

  • Transverse aortic constriction provokes significant cardiac remodeling and activates common stress pathways in young adult mice, irrespective of PLN-R14del genotype.
  • Pressure overload alone is insufficient to trigger PLN-R14del-specific sarco-endoplasmic reticulum malformation or accelerate disease progression in this model.
  • These findings suggest that common cardiac stress pathways are not the sole drivers for accelerating PLN-R14del cardiomyopathy in early adulthood.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.7K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.5K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
801
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
767
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
884
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
695